Li et al. [21] found that hs-CRP can trigger vascular endothelial injury by activating the complement system, and coagulation and fibrinolysis imbalance by activating the coagulation system and fibrinolysis system, eventually increasing the risk of cardiovascular diseases. The gene discussed is CRP; the disease is cardiovascular disorder.